Abstract
Objective: To investigate disease spread in amyotrophic lateral sclerosis (ALS), and determine the influence of lower (LMN) and upper motor neuron (UMN) involvement. Methods: We assessed disease spread in ALS in 1376 consecutively studied patients, from five European centers, applying an agreed proforma to assess LMN and UMN signs. We defined the pattern of disease onset and progression from predominant UMN or lower motor neuron (LMN) dysfunction in bulbar, upper limbs, lower limbs, and thoracic regions Non-linear regression analysis was applied to fit the data to a model that described the relation between two random variables, graphically represented by an inverse exponential curve. We analyzed the probability, rate of spread, and both combined (area under the curve). Results: We found that progression was more likely and quicker to or from the region of onset to close spinal regions. When the disease had a limb onset, bulbar motor neurons were more resistant. Furthermore, in the same time frame more patients progressed from bulbar to lower limbs than vice-versa, whether predominantly UMN or LMN involvement. Patients with initial thoracic involvement had a higher probability for rapid change. The presence of predominant UMN signs was associated with a faster caudal progression. Interpretation: Contiguous progression was leading pattern, and predominant UMN involvement is important in shortening the time for cranial-caudal spread. Our results can best be fitted to a model of independent LMN and UMN degeneration, with regional progression of LMN degeneration mostly by contiguity. UMN lesion causes an acceleration of rostral-caudal LMN loss.
| Original language | English |
|---|---|
| Journal | Annals of Clinical and Translational Neurology |
| Volume | 7 |
| Issue number | 7 |
| Pages (from-to) | 1181-1192 |
| Number of pages | 12 |
| DOIs | |
| Publication status | Published - 01.07.2020 |
Funding
This is an EU Joint Programme ‐ Neurodegenerative Disease Research (JPND) project. The project is supported through national funding organizations under the aegis of JPND ‐ www.jpnd.eu . This project was also partially supported by FCT funding to Neuroclinomics2 (PTDC/EEI‐SII/1937/2014). Patients with ALS were studied during clinical practice in five European University Hospital centers – Akdeniz University, Antalya, Turkey; Hannover University Medical School, Germany; Jena University Hospital, Germany; Faculty of Medicine, University Hospital of Lisbon, Portugal; Medical University of Warsaw, Poland. The clinical assessments, at each center, were made by a designated senior neurologist with wide clinical experience of ALS. Ethical agreement for the study was granted by the respective Clinical Ethics Committees, and each patient gave written informed consent for collection and analysis of their medical data. The study was supported by an EU research grant (EU Joint Programme Neurodegenerative Diseases Research: OnWebDUALS).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Centers: Center for Neuromuscular Diseases
DFG Research Classification Scheme
- 2.23-07 Clinical Neurology, Neurosurgery and Neuroradiology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver